Testing the Addition of an Anti-cancer Drug, Triapine, to the Usual Radiation-Based Treatment (Lutetium Lu 177 Dotatate) for Neuroendocrine Tumors
ACTIVE_NOT_RECRUITING
Status
Conditions
- Metastatic Digestive System Neuroendocrine Neoplasm
- Metastatic Neuroendocrine Tumor
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Computed Tomography
- DRUG: Lutetium Lu 177 Dotatate
- PROCEDURE: Magnetic Resonance Imaging
- DRUG: Triapine
Sponsor
National Cancer Institute (NCI)